A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2007
10/11/2007	US20070238652 Neutralization of bacterial spores
10/11/2007	US20070238649 Agents for Regulating Adiponectin Receptor Expression
10/11/2007	US20070238644 Human Chemokines CKBeta-4 and CKBeta-10/MCP-4
10/11/2007	US20070238641 Pharmaceutical Combined Preparation Containing a Therapeutic Protein
10/11/2007	US20070238640 Treating an inflammatory condition in an individual by administering an agent which inhibits the interaction between a Toll-like receptor 2 and a high mobility group B polypeptide; treating Crohn's disease, sepsis, rheumatoid arthritis, systemic lupus erythematosus, endotoxic shock, allograft rejection
10/11/2007	US20070238639 Telomerase expression repressor proteins and methods of using the same
10/11/2007	US20070238638 Bak promoter expression system
10/11/2007	US20070238178 Cancer vaccines; infections from Retrovirus, Herpesvirus, Hepadenovirus, Poxvirus, Parvovirus, Papillomavirus, or Papovavirus; reduced side effects; a hairpin RNA having a double stranded region of between 11 to 30 nucleotides; gene expression inhibition
10/11/2007	US20070238160 microorganism capable of making an isoprenoid by changing the carbon flux through geranyl pyrophosphate, farnesyl pyrophosphate, or geranylgeranyl pyrophosphate and synthesis of isopentenyl pyrophosphate from an isoprenoid pathway; production of farnesol and geranylgeraniol
10/11/2007	US20070238159 Production of Isoprenoids
10/11/2007	US20070238157 Production of Isoprenoids
10/11/2007	US20070237840 Therapeutic gastrodia extracts
10/11/2007	US20070237835 Peritoneal Dialysis Solution
10/11/2007	US20070237833 Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level
10/11/2007	US20070237832 Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level
10/11/2007	US20070237828 Ziprasidone Dosage Form
10/11/2007	US20070237827 Nanoparticles for drug delivery
10/11/2007	US20070237826 Polymerized solid lipid nanoparticles for oral or mucosal delivery of therapeutic proteins and peptides
10/11/2007	US20070237824 Sustained-Release Preparations Of Quinolone Antibiotics
10/11/2007	US20070237823 Solid Pharmaceutical Form Comprising and Ltb4 Antagonist
10/11/2007	US20070237822 Testosterone gel and method of use
10/11/2007	US20070237820 Pharmaceutical formulations containing a non-steroidal antinflammatory drug and an antiulcerative drug
10/11/2007	US20070237819 Use of sustained release oral solid dosage form; side effect reduction of liver disoders
10/11/2007	US20070237818 Controlled-release formulation of HCV protease inhibitor and methods using the same
10/11/2007	US20070237817 Polymorphic and pseudopolymorphic forms of trandolaprilat, pharmaceutical compositions and methods for production and use
10/11/2007	US20070237816 Acetaminophen formulation for joint pain relief
10/11/2007	US20070237814 Novel encochleation methods, cochleates and methods of use
10/11/2007	US20070237811 Chitosan wound dressing
10/11/2007	US20070237807 Anti-microbial hand towel with time-delay chromatic transfer indicator and absorbency rate delay
10/11/2007	US20070237787 Methods for use of tslp and agonists and antagonists thereof
10/11/2007	US20070237770 Novel compositions and methods in cancer
10/11/2007	US20070237757 Contact tumor cell expressing matrix metalloproteinase 1 with siRNA that has a sequence complementary to part of a matrix metalloproteinase 1 nucleic acid sequence specifically inhibiting synthesis or expression; cancer
10/11/2007	US20070237756 Antimicrobial preparations
10/11/2007	US20070237750 Compositions and Methods for Promoting Hair Growth
10/11/2007	US20070237744 Targeted Gene Delivery to Non-Phagocytic Mammalian Cells Via Bacterially Derived Intact Minicells
10/11/2007	US20070237742 Process for embolization using swellable and deformable microspheres
10/11/2007	US20070237741 Medical treatment applications of swellable and deformable microspheres
10/11/2007	US20070237740 Formulations and Methods for Treatment of Inflammatory Diseases
10/11/2007	US20070237739 Closed Loop Catheter Photopolymerization System and Method of Treating a Vascular Condition
10/11/2007	US20070237737 Formulation and method for a skin treatment for animals
10/11/2007	US20070237735 Anti-aging composition, kit and method of use
10/11/2007	US20070237724 Foamable suspension gel
10/11/2007	US20070237712 Methods of Redistributing Apical Target Antigens to Detect and Treat Cellular Proliferative Disease
10/11/2007	DE60022050C5 Metabotrope glutamatrezeptorantagonisten zur behandlung von krankheiten des zentralen nervensystems Metabotropic glutamate receptor antagonists for treating diseases of the central nervous system
10/11/2007	DE202007009679U1 Zusammensetzungen und Verwendungen davon zur Behandlung von Muskelschwundzuständen Compositions and uses thereof for the treatment of muscle wasting conditions
10/11/2007	DE202006009149U1 Zusammensetzung zur Verwendung als Laxativum A composition for use as a laxative
10/11/2007	DE19811540B4 Apicularen A, Verfahren zu dessen Herstellung und cytostatisches Mittel mit Apicularen A Apicularen A, processes for its preparation and cytostatic agent with apicularen A
10/11/2007	DE19701619B4 Verwendung von Pramipexol zur Behandlung des restless legs syndroms Use of pramipexole in the treatment of restless legs syndrome
10/11/2007	DE19642651B4 Verfahren und Rechnersystem zur Erkennung konformationsflexibler Moleküle Method and computer system for recognition molecules konformationsflexibler
10/11/2007	DE102006016998A1 Tetrahydronaphtol-Derivate und deren Verwendung Tetrahydronaphtol derivatives and their use
10/11/2007	DE102006016426A1 Neuartige Cyclobutyl-Verbindungen als Kinase-Inhibitoren Cyclobutyl novel compounds as kinase inhibitors
10/11/2007	DE102006016365A1 Composition for inhibiting expression of one or more target genes in a eukaryotic cell comprises one or more genetic constructs comprising a target gene and a small interfering RNA tag
10/11/2007	DE102006015734A1 Kombinationspräparate aus Modafinil, Ritalin und Topiramat und deren Derivaten zur Behandlung von Kokainabhängigkeit und/oder Impulskontrollstörung Combination preparations of Modafinil, Ritalin and topiramate and its derivatives for the treatment of cocaine dependence and / or impulse control disorder
10/11/2007	DE102006015733A1 Use of buprenorphine compounds to treat emotionally unstable personality disorder, alcohol dependence or multiple substance dependence
10/11/2007	DE102006015271A1 Biguanidhaltige Liposomen Biguanide-liposomes
10/11/2007	DE102006015140A1 Heterozyklische Verbindungen mit Wirkung gegen neurodegenerative Erkrankungen Heterocyclic compounds with activity against neurodegenerative diseases
10/11/2007	DE102005059222B4 11ß-Benzaldoximderivate von D-Homoestra-4,9-dien-3-onen 11ß-Benzaldoximderivate of D-Homoestra-4,9-dien-3-ones
10/11/2007	DE10158523B4 Hemmung der Transkription eines Zielgens in einer Zelle oder in Geweben Inhibition of transcription of a target gene in a cell or in tissue
10/11/2007	CA2778823A1 Treatments using citrulline
10/11/2007	CA2682846A1 Novel dipeptidyl peptidase iv inhibitors and processes for their preparation and pharmaceutical compositions containing them
10/11/2007	CA2649045A1 Pharmaceutical composition
10/11/2007	CA2648652A1 Compounds for diseases and disorders
10/11/2007	CA2648598A1 Lactate and calcium containing pharmaceutical composition and uses thereof
10/11/2007	CA2648503A1 Method for producing high-purity prasugrel or an acid addition salt thereof
10/11/2007	CA2648494A1 Infant treatment apparatus
10/11/2007	CA2648443A1 Substituted heterocyclic compounds and methods of use
10/11/2007	CA2648371A1 Combination therapy of (2r,z)-2-amino-2-cyclohexyl-n-(5-(1-methyl-1h-pyrazol-4-yl)-1-oxo-2,6-dihydro-1h-[1,2]diazepino[4,5,6-cd]indol-8-yl)acetamide
10/11/2007	CA2648369A1 Polymorphic forms of (2r,z)-2-amino-2-cyclohexyl-n-(5-(1-methyl-1h-pyrazol-4?l)-1-oxo-2,6-dihydro-1h-[1,2]diazepino[4,5,6-cd]indol-8-yl)acetamide
10/11/2007	CA2648351A1 Regulating fat and carbohydrate oxidation in muscle tissue
10/11/2007	CA2648162A1 Prostaglandin analogues for the treatment of glaucoma or ocular hypertension
10/11/2007	CA2648159A1 Prostaglandin ep4 agonists
10/11/2007	CA2648132A1 Pharmaceutical composition comprising anti-mirna antisense oligonucleotides
10/11/2007	CA2648087A1 Azabicyclo [3. 1. 0] hexyl derivatives as modulators of dopamine d3 receptors
10/11/2007	CA2648065A1 Piperidine derivatives useful as serotonin transporter inhibitors and neurokinin-1 receptor antagonists
10/11/2007	CA2648033A1 3,4-diamino-3-cyclobutene-1,2-dione derivatives as potassium channel openers
10/11/2007	CA2648028A1 Bicyclooctane derivatives, preparation process and pharmaceutical use thereof
10/11/2007	CA2648003A1 Orally bioavailable caffeic acid related anticancer drugs
10/11/2007	CA2647986A1 Compositions for tumor growth control
10/11/2007	CA2647982A1 Solid pharmaceutical preparation containing tramadol
10/11/2007	CA2647931A1 Increased phytosterol content through overexpression of an acyl-coa sterol acyltransferase
10/11/2007	CA2647862A1 Acid secretion inhibitor
10/11/2007	CA2647811A1 Substituted bicyclic derivative and use thereof
10/11/2007	CA2647770A1 Compositions, methods, and kits using adenosine and inosine in combination for diagnosis and treatment
10/11/2007	CA2647765A1 Coated formulations
10/11/2007	CA2647728A1 Compositions and methods for inhibiting expression of eg5 gene
10/11/2007	CA2647715A1 Light activated antiviral materials and devices and methods for decontaminating virus infected environments
10/11/2007	CA2647702A1 A tablet of paracetamol containing an encapsulated flavorant
10/11/2007	CA2647605A1 Novel compound having heterocyclic ring
10/11/2007	CA2647545A1 Amide substituted indazole and benzotriazole derivatives as poly(adp-ribose)polymerase (parp) inhibitors
10/11/2007	CA2647484A1 Dietary supplement for healing or regressing symptoms of gastroesophageal reflux disease, gastritis and ulcers
10/11/2007	CA2647472A1 Organic compounds
10/11/2007	CA2647451A1 Process for the production of carotenoid compositions
10/11/2007	CA2647445A1 N-hydroxy-3-(4-{3-phenyl-s-oxo-propenyl}-phenyl)-acrylamide derivatives and related compounds as histone deacetylase inhibitors for the treatment of cancer
10/11/2007	CA2647441A1 Immunogenic composition
10/11/2007	CA2647391A1 Kinase antagonists
10/11/2007	CA2647286A1 Polymorphic and pseudopolymorphic forms of trandolaprilat, pharmaceutical compositions and methods for production and use
10/11/2007	CA2647278A1 Thiazolyldihydroindazole derivatives as protein kinase inhibitors
10/11/2007	CA2647276A1 3',5'-di-o-acylated nucleosides for hcv treatment
10/11/2007	CA2647186A1 Use of a kinase inhibitor for the treatment of particular resistant tumors
10/11/2007	CA2646755A1 Bicyclic benzimidazole compounds and their use as metabotropic glutamate receptor potentiators

1 ... 3549 3550 3551 3552 3553 3554 3555 3556 3557 3558 3559 3560 3561 3562 3563 3564 3565 3566 3567 3568 3569 ... 7860